Who is the CEO of EvolutionaryScale?

Alexander Rives is listed as Co-founder and Chief Scientist. Public sources should be checked for leadership changes before outreach.

Where is EvolutionaryScale headquartered?

EvolutionaryScale is headquartered in New York, New York. Public office footprints can change as the company scales.

Who competes with EvolutionaryScale?

Comparable companies include Chai Discovery, Cradle, Isomorphic Labs, Generate:Biomedicines. The closest competitor depends on whether the buyer evaluates product scope, customer segment, or deployment model.

AI biology

What is EvolutionaryScale?

Q: What does EvolutionaryScale do?

EvolutionaryScale is a ai biology company. EvolutionaryScale builds frontier protein language models, including ESM3, to generate and reason about proteins across sequence, structure, and function.

Q: How much has EvolutionaryScale raised?

EvolutionaryScale has $142 million seed reported. The latest public valuation/status marker is Undisclosed.

Protein-design AI company behind the ESM3 generative biology model.

Category: AI biology
Headquarters: New York, New York
Founded: 2024
Employees: Private; research startup team
Total funding: $142 million seed reported
Status: Private

What is EvolutionaryScale?

EvolutionaryScale is a ai biology company headquartered in New York, New York.

EvolutionaryScale builds frontier protein language models, including ESM3, to generate and reason about proteins across sequence, structure, and function. The company serves research, biotech, and pharma users through model releases and partnerships; customer counts are not public.

The company was founded in 2024 and remains private. Its public profile is strongest around ESM3 and Forge / model access, while detailed revenue figures are not publicly disclosed.

As of June 2026, the safest public read is that EvolutionaryScale is scaling through enterprise partnerships and capital-intensive product development rather than a self-serve consumer motion.

Sources:EvolutionaryScale website Nature ESM3 coverage

What does EvolutionaryScale offer?

EvolutionaryScale's public product set centers on ESM3, Forge / model access, Protein generation.

ESM3· Protein model
Forge / model access· Platform
Protein generation· AI biology
Research collaborations· R&D

Sources:EvolutionaryScale website

How does EvolutionaryScale make money?

Model access, partnerships, and enterprise biology platform economics; public pricing is not disclosed.

Model access, partnerships, and enterprise biology platform economics; public pricing is not disclosed. No public list pricing; partnership/API terms are not public.

Growth is driven by enterprise adoption, strategic partnerships, and proof that the platform can deliver measurable operational, clinical, scientific, or mission outcomes. Because EvolutionaryScale does not publish standard list prices, buyers should treat budget sizing as a custom-contract exercise.

The commercial motion therefore depends on executive sponsorship, security and compliance review, and evidence that the product can integrate into existing workflows rather than replace them all at once.

Sources:EvolutionaryScale website Science esmGFP paper

Who leads EvolutionaryScale?

EvolutionaryScale is led by Alexander Rives, Co-founder and Chief Scientist.

Alexander RivesCo-founder and Chief ScientistCo-founder · since 2024Former Meta AI researcher behind the ESM protein-model family.
Tom SercuCo-founderCo-founderFormer Meta AI researcher and protein-model scientist.
Sal CandidoCo-founderCo-founderEngineering leader involved in scaling model systems.

Sources:EvolutionaryScale website Nature ESM3 coverage

Who are EvolutionaryScale's decision-makers?

How do you contact EvolutionaryScale's leadership?

Public contact route; no verified personal email pattern found. Use the listed public company route rather than guessed personal inboxes.

Email formatPublic contact route; no verified personal email pattern found

Sources:EvolutionaryScale website

How much funding has EvolutionaryScale raised?

EvolutionaryScale has $142 million seed reported and is private.

2024: Seed — $142 million, led/backed by Lux Capital, Nat Friedman, Daniel Gross and others (Valuation undisclosed).

The latest public valuation/status marker is Undisclosed. Where a valuation is undisclosed, public reporting only supports the financing amount and participating investors.

Funding is best interpreted as capacity for product build-out, hiring, regulatory or deployment work, and longer sales cycles; it should not be read as proof of profitability unless the company has separately disclosed profitability.

Sources:Nature ESM3 coverage Science esmGFP paper

How much has EvolutionaryScale raised?

How did EvolutionaryScale get here?

EvolutionaryScale's timeline runs from its 2024 founding through major financing and product milestones.

2024Founded by former Meta AI teamEvolutionaryScale spun out around the ESM protein-model lineage.
2024ESM3 introducedThe company released a frontier multimodal protein model.
2025esmGFP Science publicationResearchers reported an AI-designed fluorescent protein generated using ESM3.
2025Platform expansionThe company positioned model access for scientific and commercial use.
2026Private growthNo later disclosed round was confirmed in public sources.

Sources:EvolutionaryScale website Nature ESM3 coverage

Who are EvolutionaryScale's competitors?

EvolutionaryScale competes with specialized startups and larger platform companies in ai biology.

Chai DiscoveryMolecular structure prediction and AI biology.
CradleProtein engineering software for R&D teams.
Isomorphic LabsAI drug design and AlphaFold-related systems.
Generate:BiomedicinesGenerative protein therapeutics.

Sources:EvolutionaryScale website Science esmGFP paper

EvolutionaryScale — frequently asked questions

Revenue work. On autopilot.

Start Free TrialBuilt for revenue teams who care about quality.